awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50101328-5E6D63D6-D751-46C3-98B5-C828647BF2B7
Q50101328-5E6D63D6-D751-46C3-98B5-C828647BF2B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50101328-5E6D63D6-D751-46C3-98B5-C828647BF2B7
Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.
P2860
Q50101328-5E6D63D6-D751-46C3-98B5-C828647BF2B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50101328-5E6D63D6-D751-46C3-98B5-C828647BF2B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1fceab710bd4abe0bebf02506c8a557da6aaf0d3
P2860
A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies.